+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

  • PDF Icon

    Report

  • 82 Pages
  • May 2023
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5833548
The Latin America, Middle East and Africa Muscle Relaxant Drugs Market should witness market growth of 6.2% CAGR during the forecast period (2023-2029).

The number of fibromyalgia (FM) research articles has significantly expanded over the last few decades. This increase may be attributed to heightened awareness and common interest among a number of stakeholders, including the pharmaceutical business, patient self-help organizations, clinicians, and researchers. In addition to encouraging research to understand the underlying pathophysiology better and enhance therapy, this designation of FM will also encourage using muscle relaxants to lessen the amount of discomfort experienced by FM patients.

The rising demand for muscle relaxant treatments in the cosmetic industry and increased online sales of these medications are the primary trends that can be seen in the market for these medications. Many retailers and pharmaceutical companies have made muscle relaxant medications accessible to the public online. Online retailing has been a significant trend in the market since it makes drugs more accessible, saves time, and is more convenient while offering cheaper pricing.

Israel's population is aging more quickly than the average, much like in many other countries throughout the world. The proportion of adults 65 and older has increased by 18 since 1950. The overall population of Israel is expected to reach 12.1 million by 2035, with seniors making up roughly 14% of the total, or 1.9 million people. Only 4% of people were 65 and older in 1948 when the State of Israel was established. Over time, there has been constant growth in this population. Life expectancy has risen by 1% annually since 1995, which is expected to continue. As muscle pain-related problems are more common in older people, demand is projected to rise, spurring market expansion in LAMEA.

The Brazil market dominated the LAMEA Muscle Relaxant Drugs Market by Country in 2022 thereby, achieving a market value of $81.5 Million by 2029. The Argentina market is showcasing a CAGR of 6.8% during (2023-2029). Additionally, The UAE market would register a CAGR of 5.9% during (2023-2029).

Based on Drug Type, the market is segmented into Skeletal, Neuromuscular Blocking Agents and Facial Muscle Relaxant Drugs. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amneal Pharmaceuticals, Inc., Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Mallinckrodt PLC, Teva Pharmaceuticals Industries Ltd., Eisai Co., Ltd., Endo International PLC, Vertical Pharmaceuticals, LLC, SteriMax Inc., and Metacel Pharmaceuticals, LLC.

Scope of the Study

By Drug Type

  • Skeletal
  • Neuromuscular Blocking Agents
  • Facial Muscle Relaxant Drugs

By Route of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Amneal Pharmaceuticals, Inc.
  • Ipsen Pharma Biotech SAS
  • Merz Pharma GmbH & Co. KGaA
  • Mallinckrodt PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Eisai Co., Ltd.
  • Endo International PLC
  • Vertical Pharmaceuticals, LLC
  • SteriMax Inc.
  • Metacel Pharmaceuticals, LLC

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Muscle Relaxant Drugs Market, by Drug Type
1.4.2 LAMEA Muscle Relaxant Drugs Market, by Route of Administration
1.4.3 LAMEA Muscle Relaxant Drugs Market, by Distribution Channel
1.4.4 LAMEA Muscle Relaxant Drugs Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Muscle Relaxant Drugs Market by Drug Type
3.1 LAMEA Skeletal Market by Country
3.2 LAMEA Neuromuscular Blocking Agents Market by Country
3.3 LAMEA Facial Muscle Relaxant Drugs Market by Country
Chapter 4. LAMEA Muscle Relaxant Drugs Market by Route of Administration
4.1 LAMEA Oral Market by Country
4.2 LAMEA Injectable Market by Country
Chapter 5. LAMEA Muscle Relaxant Drugs Market by Distribution Channel
5.1 LAMEA Hospital Pharmacy Market by Country
5.2 LAMEA Retail Pharmacy Market by Country
5.3 LAMEA Online Pharmacies Market by Country
Chapter 6. LAMEA Muscle Relaxant Drugs Market by Country
6.1 Brazil Muscle Relaxant Drugs Market
6.1.1 Brazil Muscle Relaxant Drugs Market by Drug Type
6.1.2 Brazil Muscle Relaxant Drugs Market by Route of Administration
6.1.3 Brazil Muscle Relaxant Drugs Market by Distribution Channel
6.2 Argentina Muscle Relaxant Drugs Market
6.2.1 Argentina Muscle Relaxant Drugs Market by Drug Type
6.2.2 Argentina Muscle Relaxant Drugs Market by Route of Administration
6.2.3 Argentina Muscle Relaxant Drugs Market by Distribution Channel
6.3 UAE Muscle Relaxant Drugs Market
6.3.1 UAE Muscle Relaxant Drugs Market by Drug Type
6.3.2 UAE Muscle Relaxant Drugs Market by Route of Administration
6.3.3 UAE Muscle Relaxant Drugs Market by Distribution Channel
6.4 Saudi Arabia Muscle Relaxant Drugs Market
6.4.1 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type
6.4.2 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration
6.4.3 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel
6.5 South Africa Muscle Relaxant Drugs Market
6.5.1 South Africa Muscle Relaxant Drugs Market by Drug Type
6.5.2 South Africa Muscle Relaxant Drugs Market by Route of Administration
6.5.3 South Africa Muscle Relaxant Drugs Market by Distribution Channel
6.6 Nigeria Muscle Relaxant Drugs Market
6.6.1 Nigeria Muscle Relaxant Drugs Market by Drug Type
6.6.2 Nigeria Muscle Relaxant Drugs Market by Route of Administration
6.6.3 Nigeria Muscle Relaxant Drugs Market by Distribution Channel
6.7 Rest of LAMEA Muscle Relaxant Drugs Market
6.7.1 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type
6.7.2 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration
6.7.3 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Amneal Pharmaceuticals, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent Strategies and Developments
7.1.5.1 Acquisition and Mergers
7.2 Ipsen Pharma Biotech SAS
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent Strategies and Developments
7.2.5.1 Product Launches and Product Expansions
7.3 Merz Pharma GmbH & Co. KGaA
7.3.1 Company Overview
7.4 Mallinckrodt PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Endo International PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
7.8.1 Company Overview
7.9 SteriMax Inc.
7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
7.10.1 Company Overview

Companies Mentioned

  • Amneal Pharmaceuticals, Inc.
  • Ipsen Pharma Biotech SAS
  • Merz Pharma GmbH & Co. KGaA
  • Mallinckrodt PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Eisai Co., Ltd.
  • Endo International PLC
  • Vertical Pharmaceuticals, LLC
  • SteriMax Inc.
  • Metacel Pharmaceuticals, LLC

Methodology

Loading
LOADING...